MENU
IMNN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Imunon (IMNN) Ownership - Who owns Imunon?
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
33
Web
https://www.imunon.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.11M
P/E Ratio
N/A
Total Cash
5.87M
Projected Growth
N/A
Total Debt
1.14M
Revenue
N/A
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
12.33
Revenue/Share
null USD as % of share price
Fundamentals
IMNN
Capitalization
14.1M
P/E Ratio
N/A
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash
5.87M
Total Cash/Share
0.40
Total Debt
1.14M
Total Debt/Equity
12.33
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.24M
P/B Ratio
3.31
Cash Flow
N/A
Earnings
-1.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
145K
Current Ratio
1.67
Current Revenue Per Employee
4032.26
Dividends Per Share - Security
N/A
EBITDA
-17.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-117.72
Shares Held By Institutions
563K
Shares Outstanding - Current
14.6M
Total Liabilities
5.47M
Total Volume MTD
N/A
Value
N/A
Gain YTD
1.063
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the provision of oncology drug development services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
33
Web
https://www.imunon.com